← Back to all signals
RESEARCH PAPER ANALYSIS

Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021.

AI interpretation is pending for this paper.

Open original publication →
PMID41004087
JournalDermatology and therapy
Publication Date2025-09-26
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: Biologics may have altered the standard of care for pediatric psoriasis, the prevalence of which has not been studied since 2015. The objective of this study was to provide an update of the prevalence of and treatment landscape for pediatric psoriasis in the USA, highlighting the current burden of the condition and the need for improved disease awareness. METHODS: In this retrospective cohort study, US claims data (July 2015 to October 2021) from the MarketScan® database were used to estimate the prevalence of overall plaque psoriasis and moderate to severe plaque psoriasis in pediatric patients (aged 6-17 years) from 2016 to 2020. Systemic/phototherapy treatment use (per 100 patient-years [PY]) in moderate to severe pediatric patients was reported from 2017 to 2021. RESULTS: A total of 8935 pediatric patients with psoriasis were included, of whom 1448 had moderate to severe psoriasis. In 2020, the estimated overall pediatric psoriasis prevalence based on coding was 117.4/100,000, and it was 18.4/100,000 for moderate to severe psoriasis. Between 2017 and 2021, the use of non-biologic systemic treatments (2017: 36.3/100 PY; 2021: 14.1/100 PY) and phototherapy treatments (2017: 41.3/100 PY; 2021: 4.3/100 PY) decreased, while the use of biologics increased (2017: 41.5/100 PY; 2021: 56.4/100 PY). Interleukin inhibitor use increased (2017: 5.0/100 PY; 2021: 37.6/100 PY), while tumor necrosis factor (TNF) inhibitor use decreased (2017: 37.5/100 PY; 2021: 20.2/100 PY). Ustekinumab use increased the most (2017: 4.8/100 PY; 2021: 30.4/100 PY), followed by ixekizumab (2017: 0.2/100 PY; 2021: 7.2/100 PY). CONCLUSIONS: In 2020, psoriasis remained relatively uncommon among US children and adolescents, with 15.9% having moderate to severe psoriasis. Meanwhile, treatment for moderate to severe psoriasis shifted from older treatments, particularly non-biologic systemics and TNF inhibitors, toward newer, more efficacious interleukin inhibitors.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 A Longitudinal Observational Mixed Methods Cohort Study of the Psychosocial and Financial Costs of Cancer Care for Pediatric Families in the Maritimes, Canada. Cancer control : journal of the Moffitt Cancer Center 68.1 2 Impact of multidrug resistant bloodstream infection burden, prophylactic levofloxacin and rectal swab practice on children with high-risk leukemias. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 74.66 3 Case Report: Primary Cutaneous Aspergillosis in a Neutropenic Child with Pulmonary Dissemination: A case report. F1000Research 55.5 4 NIH funding in the biophotonics community. Biophotonics discovery 57.5 5 Giant Cell Tumor of the Distal Humerus: A Rare Location With a Good Response to Denosumab. Cureus 62.42 6 Peripheral Blasts at Apheresis as a Risk Factor for Survival following Tisagenlecleucel in Children and Young Adults. Blood advances 72.82 7 Envenomation-Induced Hemophagocytic Lymphohistiocytosis (HLH): First Reported Adult Case Following A Spider Bite. European journal of case reports in internal medicine 63.5 8 Rare mandibular metastasis of neuroblastoma in a child: a case report. Frontiers in dental medicine 52.3 9 Rising burden of early-onset lung cancer among Chinese adolescents and young adults (1990-2023): a Bayesian age-period-cohort analysis with projections to 2038. Frontiers in medicine 57.5 10 Immune microenvironment of infantile hemangioma: cellular dynamics, molecular networks, and emerging immunomodulatory strategies. Frontiers in immunology 67.8 11 Intranodal palisaded myofibroblastoma of the supraclavicular region in an adolescent with an HDAC2 variant: a case report. Frontiers in medicine 45.5 12 Development and validation of a prediction model for 6-month early death in pediatric H3K27M-mutant diffuse intrinsic pontine glioma (DIPG). Translational pediatrics 66.3 13 Radiofrequency ablation for severe hemangiomas with thrombocytopenia and coagulation abnormalities (Kasabach-Merritt phenomenon). Translational pediatrics 63.6 14 Global burden and trends of tracheal, bronchus, and lung cancer in adolescents and young adults: a secondary analysis of the Global Burden of Disease Study 2021. Journal of thoracic disease 67.9 15 Molecularly guided management of pediatric endobronchial inflammatory myofibroblastic tumor: a report of two cases on surgical and targeted intervention. Translational pediatrics 64.7 16 Stage-associated differences in injury and stress responses of hiPSC-derived cardiomyocytes under macrophage-derived inflammatory stimulation. Translational pediatrics 51.62 17 Glycyrrhizin alleviates Mycoplasma pneumoniae-induced acute lung injury in mice by regulating ferroptosis via the GPX4/ACSL4 axis. Journal of thoracic disease 58.0 18 Traditional Chinese medicine combined with conventional Western medicine for chronic cough following respiratory infection in children: a systematic review and meta-analysis. Translational pediatrics 84.2 19 A taurine metabolism-related gene program defines clinical and biological features of neuroblastoma and yields an 8-gene candidate prognostic model. Translational pediatrics 58.7 20 Diagnostic and therapeutic value of double-balloon enteroscopy in pediatric patients with Peutz-Jeghers syndrome. Translational pediatrics 64.74 21 Intratumoral and peritumoral-based radiomics for assessment of lymphovascular invasion in invasive breast cancer: model development and validation. Translational cancer research 64.9 22 Development and validation of a predictive model for thyroid nodule malignancy risk based on intralesional and perilesional ultrasound radiomic features. Gland surgery 67.0 23 Advanced esophageal adenocarcinoma in a pediatric patient with Down syndrome: a rare case report and literature review. Annals of medicine and surgery (2012) 55.4 24 First case description of a highly aggressive thoracopulmonary primitive neuroectodermal tumor in a Moroccan adult male. Annals of medicine and surgery (2012) 56.7 25 DAT-negative autoimmune hemolytic anemia following acute hepatitis a in a pediatric patient with elevated IgA: a rare case report and literature review. Annals of medicine and surgery (2012) 55.0 26 Exploring New Frontiers in Osteosarcoma Treatment: Clinical Trial Insights. Recent patents on anti-cancer drug discovery 85.44 27 Pediatric low-grade glial, glioneuronal and neuronal tumors: a retrospective study of 85 cases. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 63.0 28 Outcomes of Pediatric Precursor B Cell Acute Lymphoblastic Leukemia: A Tertiary Care Cancer Center Experience from a Lower-Middle-Income Country. Journal of cancer & allied specialties 67.4 29 Long-Term Survival Patterns in Childhood B-Cell Non-Hodgkin Lymphoma in Resource-Constrained Countries. Journal of cancer & allied specialties 74.42 30 Outcomes of Methotrexate-Based Therapy for Paediatric Osteosarcoma: A Decade of Experience from a Cancer Centre in Pakistan. Journal of cancer & allied specialties 71.74 31 Late Anthracycline Cardiotoxicity Mimicking Arrhythmogenic Cardiomyopathy in a Young Adult. JACC. Case reports 55.62 32 Spontaneous complete regression of congenital brain tumors - a systematic literature review and case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 66.0
PATIENT-FRIENDLY SUMMARY

Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic